The Johnson & Johnson Vaccine Pause Explained

This week, an unusual disagreement broke out between the president of the United States and Pope Leo XIV. The New York Times Rome bureau chief, Motoko Rich, explains why President Trump cares so much about what the pope thinks, and why it matters that they are so deeply at odds. ...  Show more

Over a month into a war with Iran that has no clear end, President Trump has enforced a blockade, which went into effect on Monday at the Strait of Hormuz. The New York Times reporters David E. Sanger, Rebecca F. Elliott and Eric Schmitt discuss the strategy behind the blockade, ...  Show more

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

The Centers for Disease Control and Prevention and the Food and Drug Administration announced a recommended pause in use of Johnson & Johnson's single-use COVID-19 vaccine, while the agencies investigate reports of a rare but serious blood clot in six people. The pause comes at a ...  Show more

The CDC and the FDA have lifted their recommended pause on the Johnson and Johnson COVID vaccine, and added a warning label about the very, very rare reported cases of blood clots. But overall vaccination rates in the US are slowing down, indicating that while supply is increasin ...  Show more

The U.S. Food and Drug administration found the Johnson & Johnson coronavirus vaccine is safe and effective and meets the emergency use authorization requirements. If authorized, it’ll be the third shot option in the United States. Dr. Leana Wen is the former Baltimore Health Com ...  Show more